Job Detail

Roche Product Development Neuroscience (PDN) is seeking a Clinical Scientist/ Senior Clinical Scientist (CS/Sr. CS) to join its anti-myostatin adnectin (RG6206) development team.  RG6206 is being developed as a potential best-in-disease therapy for the treatment of Duchenne Muscular Dystrophy, a progressive, life-shortening genetic disorder mainly affecting young boys.  RG6206 is also being considered as a potential treatment for other muscle-wasting conditions.  The CS/Sr. CS assists the Clinical Science Leader (CSL) in all areas of project and study planning, evaluation, documentation and medical monitoring, including IND and annual report development, protocol development, medical monitoring for patients in the program and ongoing clinical review for safety. You would be responsible for all scientific aspects in a study.

• You assist in the timely medically and scientifically sound development of the clinical portions of an integrated development plan (IDP).


• You assist with the quality and timely preparation of all Product Development Clinical (PDC) documents submitted for approval.


• You liaise with appropriate departments inside and outside PDC to support interactions with the FDA and other regulatory bodies.


• You ensure correct data interpretation including interim and Final Study Reports before they are approved.


• You liaise and communicate with Commercial and Medical Affairs and coordinate clinical efforts on the project-related issues and you assist in the preparation of abstracts, posters, and oral communication for scientific meetings.

Who you are:

You’re someone who wants to influence your own development. You’re looking to be part of a dynamic and growing organization where you have the opportunity to pursue your interests across functions and geographies. Where a job title is not considered the final definition of who you are, but the starting point.

We are looking for a professional with a PhD or equivalent qualification, good medical competence, and experience in clinical trials, preferably Phase II / III. A basic or clinical research background in pediatric, rare, and/or neuromuscular (e.g., DMD, SMA) diseases is preferred. In addition:

• Have a good clinical research experience in working on a clinical team (or equivalent) and in working in a diverse environment


• Are a strong team player, you have the ability to broaden one's knowledge base and to get “up to speed” on a new indication within six months


• Are able to evaluate, interpret & synthesize scientific data, you can verbally present and critically discuss clinical trial data in internal and external meetings


• You have excellent verbal & written communication skills in English. You have an international perspective.

Roche is an equal opportunity employer.